BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1280 related articles for article (PubMed ID: 11773440)

  • 1. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
    Filardo EJ; Quinn JA; Frackelton AR; Bland KI
    Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
    Filardo EJ; Quinn JA; Bland KI; Frackelton AR
    Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
    Chen Y; Li Z; He Y; Shang D; Pan J; Wang H; Chen H; Zhu Z; Wan L; Wang X
    Toxicol Appl Pharmacol; 2014 Mar; 275(2):176-81. PubMed ID: 24440569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17-Beta-estradiol inhibits transforming growth factor-beta signaling and function in breast cancer cells via activation of extracellular signal-regulated kinase through the G protein-coupled receptor 30.
    Kleuser B; Malek D; Gust R; Pertz HH; Potteck H
    Mol Pharmacol; 2008 Dec; 74(6):1533-43. PubMed ID: 18768737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.
    Maggiolini M; Vivacqua A; Fasanella G; Recchia AG; Sisci D; Pezzi V; Montanaro D; Musti AM; Picard D; Andò S
    J Biol Chem; 2004 Jun; 279(26):27008-16. PubMed ID: 15090535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells.
    Watters JJ; Chun TY; Kim YN; Bertics PJ; Gorski J
    Mol Endocrinol; 2000 Nov; 14(11):1872-81. PubMed ID: 11075818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction Between CCL18 and GPR30 Differs from the Interaction Between Estradiol and GPR30.
    Schmidt-Wolf R; Zissel G
    Anticancer Res; 2020 Jun; 40(6):3097-3108. PubMed ID: 32487604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells.
    Thomas P; Pang Y; Filardo EJ; Dong J
    Endocrinology; 2005 Feb; 146(2):624-32. PubMed ID: 15539556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17beta-estradiol on mouse spermatogonial GC-1 cell line.
    Sirianni R; Chimento A; Ruggiero C; De Luca A; Lappano R; Andò S; Maggiolini M; Pezzi V
    Endocrinology; 2008 Oct; 149(10):5043-51. PubMed ID: 18566133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer.
    Filardo EJ
    J Steroid Biochem Mol Biol; 2002 Feb; 80(2):231-8. PubMed ID: 11897506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release.
    Filardo EJ; Thomas P
    Trends Endocrinol Metab; 2005 Oct; 16(8):362-7. PubMed ID: 16125968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-protein-coupled receptor 30/adenylyl cyclase/protein kinase A pathway is involved in estradiol 17ß-D-glucuronide-induced cholestasis.
    Zucchetti AE; Barosso IR; Boaglio AC; Basiglio CL; Miszczuk G; Larocca MC; Ruiz ML; Davio CA; Roma MG; Crocenzi FA; Pozzi EJ
    Hepatology; 2014 Mar; 59(3):1016-29. PubMed ID: 24115158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
    Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
    Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells.
    Albanito L; Sisci D; Aquila S; Brunelli E; Vivacqua A; Madeo A; Lappano R; Pandey DP; Picard D; Mauro L; Andò S; Maggiolini M
    Endocrinology; 2008 Aug; 149(8):3799-808. PubMed ID: 18467441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells.
    Chen DB; Bird IM; Zheng J; Magness RR
    Endocrinology; 2004 Jan; 145(1):113-25. PubMed ID: 14512434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.
    Lappano R; Santolla MF; Pupo M; Sinicropi MS; Caruso A; Rosano C; Maggiolini M
    Breast Cancer Res; 2012 Jan; 14(1):R12. PubMed ID: 22251451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-alpha knock-out mice.
    Singh M; Sétáló G; Guan X; Frail DE; Toran-Allerand CD
    J Neurosci; 2000 Mar; 20(5):1694-700. PubMed ID: 10684871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells.
    Oh AS; Lorant LA; Holloway JN; Miller DL; Kern FG; El-Ashry D
    Mol Endocrinol; 2001 Aug; 15(8):1344-59. PubMed ID: 11463858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prolonged hydroxytamoxifen treatment of MCF-7 cells on mitogen activated kinase cascade.
    Rabenoelina F; Semlali A; Duchesne MJ; Freiss G; Pons M; Badia E
    Int J Cancer; 2002 Apr; 98(5):698-706. PubMed ID: 11920638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prunetin signals via G-protein-coupled receptor, GPR30(GPER1): Stimulation of adenylyl cyclase and cAMP-mediated activation of MAPK signaling induces Runx2 expression in osteoblasts to promote bone regeneration.
    Khan K; Pal S; Yadav M; Maurya R; Trivedi AK; Sanyal S; Chattopadhyay N
    J Nutr Biochem; 2015 Dec; 26(12):1491-501. PubMed ID: 26345541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.